X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (781) 781
Publication (153) 153
Book Review (48) 48
Conference Proceeding (44) 44
Book Chapter (9) 9
Book / eBook (1) 1
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (495) 495
humans (479) 479
hematology (461) 461
transplantation (417) 417
adult (333) 333
male (326) 326
female (317) 317
middle aged (299) 299
immunology (253) 253
adolescent (216) 216
aged (183) 183
hematology, oncology and palliative medicine (176) 176
article (167) 167
child (158) 158
transplantation, homologous (136) 136
abridged index medicus (133) 133
hematopoietic stem cells (133) 133
treatment outcome (126) 126
child, preschool (125) 125
bone-marrow-transplantation (121) 121
hematopoietic stem cell transplantation (117) 117
bone marrow (102) 102
young adult (96) 96
survival analysis (95) 95
retrospective studies (94) 94
infant (89) 89
stem-cell transplantation (89) 89
disease-free survival (88) 88
cancer (85) 85
survival (85) 85
bone marrow transplantation (81) 81
leukemia (81) 81
hematopoietic stem cell transplantation - adverse effects (79) 79
risk factors (79) 79
oncology (76) 76
recurrence (75) 75
analysis (71) 71
hematopoietic stem cell transplantation - methods (71) 71
mortality (69) 69
survival rate (68) 68
acute myeloid-leukemia (66) 66
versus-host-disease (65) 65
chemotherapy (64) 64
therapy (63) 63
prognosis (62) 62
stem cells (61) 61
hemic and lymphatic diseases (58) 58
transplantation conditioning - methods (58) 58
graft vs host disease - etiology (57) 57
acute disease (55) 55
graft vs host disease - mortality (53) 53
leukemia, myeloid, acute - therapy (52) 52
bone-marrow (50) 50
relapse (50) 50
unrelated donors (50) 50
adults (49) 49
bone marrow transplantation - adverse effects (49) 49
risk (49) 49
surgical procedures, operative (49) 49
graft vs host disease - prevention & control (48) 48
chronic disease (47) 47
health aspects (47) 47
tissue donors (46) 46
transplantation conditioning (46) 46
hematologic neoplasms - therapy (45) 45
prospective studies (45) 45
remission induction (44) 44
blood (43) 43
research (43) 43
acute myelogenous leukemia (42) 42
incidence (42) 42
cohort studies (41) 41
follow-up studies (41) 41
aml (40) 40
care and treatment (40) 40
time factors (40) 40
allogeneic transplantation (39) 39
transplantation, autologous (39) 39
children (37) 37
hematopoietic-cell transplantation (37) 37
histocompatibility testing (37) 37
medical research (37) 37
outcomes (37) 37
recipients (37) 37
graft vs host disease - epidemiology (35) 35
immune system diseases (34) 34
graft vs host disease - pathology (33) 33
age factors (31) 31
bone-marrow transplantation (31) 31
medicine, experimental (31) 31
precursor cell lymphoblastic leukemia-lymphoma - therapy (31) 31
clinical trials (30) 30
graft vs host disease - drug therapy (30) 30
graft-versus-host disease (30) 30
hematopoietic stem cell transplantation - mortality (30) 30
siblings (29) 29
umbilical-cord blood (29) 29
combined modality therapy (28) 28
oncology, experimental (28) 28
risk-factors (28) 28
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Infectious Diseases, ISSN 1058-4838, 9/2012, Volume 55, Issue 6, pp. 764 - 770
Background. Enterococci are an important cause of healthcare-associated infections. We retrospectively analyzed risk factors and outcome of... 
Enterococcus | Pediatrics | Mortality | Predisposing factors | Bone marrow | Infections | Transplantation | ARTICLES AND COMMENTARIES | Bacteremia | Blood | Myelodysplastic syndromes | INFECTIOUS DISEASES | BLOOD-STREAM INFECTION | FAECIUM | VANCOMYCIN-RESISTANT ENTEROCOCCUS | VRE BACTEREMIA | MICROBIOLOGY | COMPETING RISKS | NEUTROPENIC PATIENTS | COLONIZATION | IMMUNOLOGY | INTENSIVE-CARE | FAECALIS BACTEREMIA | OUTBREAK | Humans | Middle Aged | Cross Infection - mortality | Gram-Positive Bacterial Infections - mortality | Child, Preschool | Bacteremia - mortality | Infant | Male | Minnesota - epidemiology | Bacteremia - microbiology | Young Adult | Enterococcus - isolation & purification | Gram-Positive Bacterial Infections - microbiology | Hematopoietic Stem Cell Transplantation - adverse effects | Adult | Female | Retrospective Studies | Child | Cross Infection - epidemiology | Transplantation, Homologous - adverse effects | Risk Factors | Hospitals, University | Vancomycin Resistance | Treatment Outcome | Gram-Positive Bacterial Infections - epidemiology | Cross Infection - microbiology | Adolescent | Survival Analysis | Bacteremia - epidemiology | Aged | Prevention | Usage | Prognosis | Patient outcomes | Stem cells | Research | Health aspects | Risk factors | Disease prevention | Bacterial infections | Drug resistance | Index Medicus | Indexing in process | and Commentaries
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2011, Volume 12, Issue 13, pp. 1195 - 1203
Journal Article
by Mathew, Nimitha R and Baumgartner, Francis and Braun, Lukas and O'Sullivan, David and Thomas, Simone and Waterhouse, Miguel and Müller, Tony A and Hanke, Kathrin and Taromi, Sanaz and Apostolova, Petya and Illert, Anna L and Melchinger, Wolfgang and Duquesne, Sandra and Schmitt-Graeff, Annette and Osswald, Lena and Yan, Kai-Li and Weber, Arnim and Tugues, Sonia and Spath, Sabine and Pfeifer, Dietmar and Follo, Marie and Claus, Rainer and Lübbert, Michael and Rummelt, Christoph and Bertz, Hartmut and Wäsch, Ralph and Haag, Johanna and Schmidts, Andrea and Schultheiss, Michael and Bettinger, Dominik and Thimme, Robert and Ullrich, Evelyn and Tanriver, Yakup and Vuong, Giang Lam and Arnold, Renate and Hemmati, Philipp and Wolf, Dominik and Ditschkowski, Markus and Jilg, Cordula and Wilhelm, Konrad and Leiber, Christian and Gerull, Sabine and Halter, Jörg and Lengerke, Claudia and Pabst, Thomas and Schroeder, Thomas and Kobbe, Guido and Rösler, Wolf and Doostkam, Soroush and Meckel, Stephan and Stabla, Kathleen and Metzelder, Stephan K and Halbach, Sebastian and Brummer, Tilman and Hu, Zehan and Dengjel, Joern and Hackanson, Björn and Schmid, Christoph and Holtick, Udo and Scheid, Christof and Spyridonidis, Alexandros and Stölzel, Friedrich and Ordemann, Rainer and Müller, Lutz P and Sicre-De-Fontbrune, Flore and Ihorst, Gabriele and Kuball, Jürgen and Ehlert, Jan E and Feger, Daniel and Wagner, Eva-Maria and Cahn, Jean-Yves and Schnell, Jacqueline and Kuchenbauer, Florian and Bunjes, Donald and Chakraverty, Ronjon and Richardson, Simon and Gill, Saar and Kröger, Nicolaus and Ayuk, Francis and Vago, Luca and Ciceri, Fabio and Müller, Antonia M and Kondo, Takeshi and Teshima, Takanori and Klaeger, Susan and Kuster, Bernhard and Kim, Dennis H and Weisdorf, Daniel and Van Der Velden, Walter and Dörfel, Daniela and Bethge, Wolfgang and Hilgendorf, Inken and Hochhaus, Andreas and Andrieux, Geoffroy and Börries, Melanie and Busch, Hauke and Magenau, John and Reddy, Pavan and Labopin, Myriam and Antin, Joseph H and ...
Nature Medicine, ISSN 1078-8956, 03/2018, Volume 24, Issue 3, pp. 282 - 291
Individuals with acute myeloid leukemia (AML) harboring an internal tandem duplication (ITD) in the gene encoding Fms-related tyrosine kinase 3 (FLT3) who... 
ALLO-SCT | MEDICINE, RESEARCH & EXPERIMENTAL | INTERNAL TANDEM DUPLICATION | CONTROLLED-TRIAL | ACUTE GVHD | BIOCHEMISTRY & MOLECULAR BIOLOGY | REGULATORY FACTOR | ACUTE MYELOID-LEUKEMIA | TUMOR ACTIVITY | CELL BIOLOGY | ACUTE LYMPHOBLASTIC-LEUKEMIA | HOST-DISEASE | SEQUENCING DATA | Sorafenib - administration & dosage | Leukemia, Myeloid, Acute - pathology | Humans | Activating Transcription Factor 4 - genetics | Sorafenib - adverse effects | Interferon Regulatory Factor-7 - genetics | Graft vs Host Disease - pathology | fms-Like Tyrosine Kinase 3 - genetics | Graft vs Host Disease - genetics | Animals | Interleukin-15 - genetics | Graft vs Host Disease - drug therapy | Hematopoietic Stem Cell Transplantation - adverse effects | Leukemia, Myeloid, Acute - drug therapy | Mice | Gene Expression Regulation, Neoplastic - drug effects | CD8-Positive T-Lymphocytes - immunology | Cellular Reprogramming - genetics | Tandem Repeat Sequences - genetics | Leukemia, Myeloid, Acute - genetics | Transplantation, Homologous - adverse effects | Interleukin-15 | Gene mutations | Gene expression | Health aspects | Chromatin | Animal models | Bcl-2 protein | PD-1 protein | CD8 antigen | Leukemia | Activation | Transplantation | Lymphocytes T | Synergism | Mitochondria | Cell activation | Lymphocytes | Rodents | Transcription activation | Flexible manufacturing systems | Protein-tyrosine kinase | Tyrosine | Cell survival | Myeloid leukemia | Activating transcription factor 4 | Interleukin 15 | Survival | Cells | Hemopoiesis | Interferon regulatory factor 7 | γ-Interferon | Glycolysis | Interferon | Acute myeloid leukemia | Interferon regulatory factor | Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2012, Volume 367, Issue 16, pp. 1487 - 1496
In this study of unrelated-donor transplantation for hematologic cancers, survival was similar with bone marrow and peripheral-blood stem-cell grafts. However,... 
PROGENITOR CELLS | ALLOGENEIC TRANSPLANTATION | MEDICINE, GENERAL & INTERNAL | COLONY-STIMULATING FACTOR | TERM-FOLLOW-UP | RANDOMIZED-TRIAL | MALIGNANCIES | LEUKEMIA | RECIPIENTS | VERSUS-HOST-DISEASE | CHRONIC GRAFT | Recurrence | Graft vs Host Disease - epidemiology | Peripheral Blood Stem Cell Transplantation - adverse effects | Histocompatibility Testing | Humans | Bone Marrow Diseases - mortality | Kaplan-Meier Estimate | Proportional Hazards Models | Leukemia - therapy | Peripheral Blood Stem Cell Transplantation - mortality | Male | Survival Rate | Cause of Death | Graft Rejection - epidemiology | Bone Marrow Transplantation - mortality | Bone Marrow Diseases - therapy | Intention to Treat Analysis | Bone Marrow Transplantation - adverse effects | Adult | Female | Unrelated Donors | Leukemia - mortality | Patient outcomes | Stem cells | Causes of | Bone marrow | Graft versus host reaction | Transplantation | Diagnosis | Comparative analysis | Graft-versus-host reaction | Cell survival | Transplants & implants | Risk groups | Syngeneic grafts | Mortality | Clinical trials | Bone marrow transplantation | Stem cell transplantation | Cardiovascular disease | Genetic diversity | Hematopoietic stem cells | Risk factors | Quality of life | Rejection | Grafts | Motivation | Peripheral blood | Histocompatibility antigen HLA | Index Medicus | Abridged Index Medicus
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 03/2018, Volume 24, Issue 3, pp. S84 - S85
Journal Article
Journal Article
Blood, ISSN 0006-4971, 08/2015, Volume 126, Issue 8, pp. 1033 - 1040
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2012, Volume 366, Issue 19, pp. 1770 - 1781
Journal Article
American Journal of Hematology, ISSN 0361-8609, 03/2016, Volume 91, Issue 3, pp. 322 - 329
Journal Article